Prevalence of BRAF and NRAS mutations in fast-growing melanomas

Pigment Cell and Melanoma Research

Volumn 26, Issue 3, 2013, Pages 429-431

  Nagore, Eduardo ^a,b   Hacker, Elke ^c,d   Martorell Calatayud, Antonio ^a   Traves, Víctor ^a   Guillen, Carlos ^a   Hayward, Nicholas K ^c   Whiteman, David ^c  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; NRAS PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LETTER; MALE; MELANOMA; OBSERVATIONAL STUDY; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; DEMOGRAPHY; DNA MUTATIONAL ANALYSIS; FEMALE; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PREVALENCE; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 84876813355     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12082     Document Type: Letter

References (14)

1. Akslen, L.A., Angelini, S., Straume, O. et al. (2005). BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. J. Invest. Dermatol. 125, 312-317.
2. Bauer, J., Buttner, P., Murali, R. et al. (2011). BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 24, 345-351.
3. Edlundh-Rose, E., Egyhazi, S., Omholt, K. et al. (2006). NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16, 471-478.
4. Ellerhorst, J.A., Greene, V.R., Ekmekcioglu, S. et al. (2010). Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin. Cancer Res. 17, 229-235.
5. El-Osta, H., Falchook, G., Tsimberidou, A. et al. (2011). BRAF mutations in advanced cancers: clinical characteristics and outcomes. PLoS ONE 6, e25806.
6. Grob, J.J., Richard, M.A., Gouvernet, J. et al. (2002). The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study. Int. J. Cancer 102, 34-38.
7. Hacker, E., Hayward, N.K., Dumenil, T., James, M.R., and Whiteman, D.C. (2010). The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. J. Invest. Dermatol. 130, 241-248.
8. Lipsker, D. (2006). Growth rate, early detection, and prevention of melanoma: melanoma epidemiology revisited and future challenges. Arch. Dermatol. 142, 1638-1640.
9. Lipsker, D., Engel, F., Cribier, B. et al. (2007). Trends in melanoma epidemiology suggest three different types of melanoma. Br. J. Dermatol. 157, 338-343.
10. Liu, W., Dowling, J.P., Murray, W.K. et al. (2006). Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch. Dermatol. 142, 1551-1558.
11. Long, G.V., Menzies, A.M., Nagrial, A.M. et al. (2011). Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J. Clin. Oncol. 29, 1239-1246.
12. Martorell-Calatayud, A., Nagore, E., Botella-Estrada, R. et al. (2011). Defining fast-growing melanomas: reappraisal of epidemiological, clinical, and histological features. Melanoma Res. 21, 131-138.
13. Nagore, E., Botella-Estrada, R., Requena, C. et al. (2009). Clinical and epidemiologic profile of melanoma patients according to sun exposure of the tumor site. Actas. Dermosifiliogr. 100, 205-211.
14. Thomas, N.E., Edmiston, S.N., Alexander, A. et al. (2007). Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol. Biomarkers Prev. 16, 991-997.